Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Insider Trading: Important Buys at AGCO and Echo Global Logistics, While Pacira Pharmaceuticals Sees a Sale

By

Plus, a purchase at Towerstream Corporation.

PrintPRINT
Welcome to our daily round-up of top insider trades. Here's a look at the most significant inside sales and purchases filed with the SEC on Monday, March 25, 2013.

Purchases: Mallika Srinivasan, a Director of agricultural equipment company AGCO Corporation (NYSE:AGCO), bought 172,833 shares of company stock, worth $8,799,708. US farm equipment sales have been down with weaker commodity futures, and last week, Andrew Casey of Wells Fargo lowered ratings for both AGCO and Deere & Company (NYSE:DE) to Under Perform from Market Perform.

At Echo Global Logistics (NASDAQ:ECHO), Director John Walter bought 33,321 shares of company stock, worth $695,217. Echo Global Logistics provides technology-enabled transportation and supply chain management services. On March 19, the company announced that it had acquired the truckload brokerage firm Open Mile Inc., which develops cloud-based technology for automating the manual tasks of transportation management.

Howard Haronian, a Director of broadband services company Towerstream Corporation (NASDAQ:TWER), bought 21,000 shares of company stock, worth $49,425. Towerstream provides broadband services to commercial customers and delivers wireless network access over regulated and unregulated radio spectrum.

Sales: At Pacira Pharmaceuticals (NASDAQ:PCRX), Swiss venture capital company HBM Healthcare Investments (SWX:HBMN), which invests in emerging biotechnology and pharmaceutical companies, sold 290,000 shares of company stock for $8,130,686. Pacira is a global specialty pharmaceutical company that develops and manufactures products for use in hospital and ambulatory surgery centers. The company is developing Exparel, a long-acting anesthetic/analgesic for post-surgical pain management that provides significant pain relief for up to 72 hours after surgery. The drug is expected to address an unmet medical need for a long-lasting non-opioid post-surgical painkiller as it gains approval for additional procedures.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
DIR
AB
$8,799,708
2
DIR
B
$695,217
3
DIR
JB*
$420,000
4
CEO,CB,BO
B
$110,225
5
DIR
B
$49,425
6
DIR
B
$30,783
7
DIR
B
$27,000
8
CAO,VP
B
$19,710
9
DIR
B
$16,500
10
DIR
B
$16,200

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
CB,DIR
AS
$64,979,780
2
BO
JS*
$53,888,000
3
CEO,PR,DIR
AS
$14,334,881
4
BO
AS
$8,130,686
5
CB,DIR,BO
AS
$3,513,608
6
O
AS
$1,785,765
7
BO
S
$1,652,952
8
DIR
S
$1,586,200
9
DIR
S
$1,454,764
10
DIR
AS
$1,041,866

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights:

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of "Profit From Legal Insider Trading."
< Previous
  • 1
Next >
No positions in stocks mentioned.
PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE